Free Trial
NASDAQ:IRTC

iRhythm Technologies (IRTC) Stock Price, News & Analysis

iRhythm Technologies logo
$132.88 -1.75 (-1.30%)
Closing price 07/9/2025 04:00 PM Eastern
Extended Trading
$132.93 +0.05 (+0.03%)
As of 07/9/2025 06:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About iRhythm Technologies Stock (NASDAQ:IRTC)

Key Stats

Today's Range
$129.48
$135.95
50-Day Range
$108.59
$154.71
52-Week Range
$55.92
$157.13
Volume
767,168 shs
Average Volume
487,173 shs
Market Capitalization
$4.24 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$138.60
Consensus Rating
Moderate Buy

Company Overview

iRhythm Technologies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
21st Percentile Overall Score

IRTC MarketRank™: 

iRhythm Technologies scored higher than 21% of companies evaluated by MarketBeat, and ranked 839th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    iRhythm Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.90, and is based on 9 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    iRhythm Technologies has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about iRhythm Technologies' stock forecast and price target.
  • Earnings Growth

    Earnings for iRhythm Technologies are expected to grow in the coming year, from ($1.98) to ($1.03) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of iRhythm Technologies is -42.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of iRhythm Technologies is -42.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    iRhythm Technologies has a P/B Ratio of 45.82. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about iRhythm Technologies' valuation and earnings.
  • Percentage of Shares Shorted

    8.17% of the float of iRhythm Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    iRhythm Technologies has a short interest ratio ("days to cover") of 5.4.
  • Change versus previous month

    Short interest in iRhythm Technologies has recently increased by 5.31%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    iRhythm Technologies does not currently pay a dividend.

  • Dividend Growth

    iRhythm Technologies does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    8.17% of the float of iRhythm Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    iRhythm Technologies has a short interest ratio ("days to cover") of 5.4.
  • Change versus previous month

    Short interest in iRhythm Technologies has recently increased by 5.31%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    iRhythm Technologies has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for iRhythm Technologies this week, compared to 6 articles on an average week.
  • Search Interest

    Only 2 people have searched for IRTC on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, iRhythm Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $796,882.00 in company stock.

  • Percentage Held by Insiders

    Only 1.10% of the stock of iRhythm Technologies is held by insiders.

  • Read more about iRhythm Technologies' insider trading history.
Receive IRTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter.

IRTC Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
iRhythm Technologies Announces Board Member Changes
See More Headlines

IRTC Stock Analysis - Frequently Asked Questions

iRhythm Technologies' stock was trading at $90.17 on January 1st, 2025. Since then, IRTC stock has increased by 47.4% and is now trading at $132.88.

iRhythm Technologies (NASDAQ:IRTC) issued its quarterly earnings results on Thursday, May, 1st. The company reported ($0.95) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.89) by $0.06. iRhythm Technologies's revenue for the quarter was up 20.3% on a year-over-year basis.
Read the conference call transcript
.

iRhythm Technologies (IRTC) raised $76 million in an IPO on Thursday, October 20th 2016. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

iRhythm Technologies' top institutional investors include Harbor Capital Advisors Inc. (0.09%) and MRA Advisory Group (0.01%). Insiders that own company stock include Quentin S Blackford, Mark J Day, Chad Patterson, Minang Turakhia, Daniel G Wilson, Patrick Michael Murphy, Douglas Devine, Brice Bobzien, Sumi Shrishrimal, Abhijit Y Talwalkar, Mervin Smith, Marc W Rosenbaum and Merz Cathleen Noel Bairey.
View institutional ownership trends
.

Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iRhythm Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Advanced Micro Devices (AMD), Arista Networks (ANET) and ServiceNow (NOW).

Company Calendar

Last Earnings
5/01/2025
Today
7/09/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:IRTC
CIK
1388658
Fax
N/A
Employees
2,000
Year Founded
N/A

Price Target and Rating

High Price Target
$167.00
Low Price Target
$100.00
Potential Upside/Downside
+4.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.90
Research Coverage
10 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$113.29 million
Pretax Margin
-15.70%

Debt

Sales & Book Value

Annual Sales
$618.59 million
Price / Cash Flow
N/A
Book Value
$2.90 per share
Price / Book
45.82

Miscellaneous

Free Float
31,708,000
Market Cap
$4.24 billion
Optionable
Optionable
Beta
1.41

Social Links

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:IRTC) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners